Role of innate inflammation in traumatic brain injury
- 19 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 42 (4), 1287-1299
- https://doi.org/10.1007/s10072-020-05002-3
Abstract
Traumatic brain injury is one of the leading causes of morbidity and mortality throughout the world. Its increasing incidence, in addition to its fundamental role in the development of neurodegenerative disease, proves especially concerning. Despite extensive preclinical and clinical studies, researchers have yet to identify a safe and effective neuroprotective strategy. Following brain trauma, secondary injury from molecular, metabolic, and cellular changes causes progressive cerebral tissue damage. Chronic neuroinflammation following traumatic brain injuries is a key player in the development of secondary injury. Targeting this phenomenon for development of effective neuroprotective therapies holds promise. This strategy warrants a concrete understanding of complex neuroinflammatory mechanisms. In this review, we discuss pathophysiological mechanisms such as the innate immune response, glial activation, blood-brain barrier disruption, activation of immune mediators, as well as biological markers of traumatic brain injury. We then review existing and emerging pharmacological therapies that target neuroinflammation to improve functional outcome.Keywords
This publication has 124 references indexed in Scilit:
- Damage to Myelin and Oligodendrocytes: A Role in Chronic Outcomes Following Traumatic Brain Injury?Brain Sciences, 2013
- Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury modelFrontiers in Pharmacology, 2013
- Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expressionJournal of Neuroinflammation, 2012
- Blood–Brain Barrier Pathophysiology in Traumatic Brain InjuryTranslational Stroke Research, 2011
- The NLRP3 inflammasome in health and disease: the good, the bad and the uglyClinical and Experimental Immunology, 2011
- Inflammation after trauma: Microglial activation and traumatic brain injuryAnnals of Neurology, 2011
- Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injuryJournal of Neuroinflammation, 2010
- Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2009
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusionJournal of Neuroimmunology, 2007